A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants

Name: A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants
Published: 2022
License: Public Domain

ViiV Healthcare · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

hiv hiv-infections pharmacokinetics safety

hiv infections, vh3810109, gsk3810109, hiv, human monoclonal antibody, rhuph20, pharmacokinetics, safety, tolerability, n6ls, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants

Related documents